Cdk1-mediated phosphorylation of human ATF7 at Thr-51 and Thr-53 promotes cell-cycle progression into M phase

Hitomi Hasegawa1, Kenichi Ishibashi1, Shoichi Kubota1

  • 1Department of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Plos One
|December 30, 2014
PubMed

Insights

Activating transcription factor 2 (ATF2) and ATF7 are phosphorylated during mitosis by Cdk1-cyclin B1, promoting cell division. Mitotic phosphorylation of ATF7 is crucial for G2/M progression and Aurora kinase activation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Activating transcription factor 2 (ATF2) and ATF7 regulate gene transcription in G1 and S phases via stress-activated MAPK phosphorylation.
  • The role of ATF2 and ATF7 in the G2/M phase of the cell cycle remains largely uncharacterized.

Purpose of the Study:

  • To investigate the function of ATF2 and ATF7 during the G2/M phase.
  • To elucidate the regulatory mechanisms of ATF2 and ATF7 phosphorylation in mitosis.

Main Methods:

  • Western blotting to detect phosphorylation.
  • Cell proliferation assays.
  • Mitotic progression analysis using knockdown and inducible expression systems.
  • Kinase activity assays.

Main Results:

  • Cdk1-cyclin B1 phosphorylates ATF2 and ATF7 at specific threonine residues during early mitosis (prophase to anaphase) without stress.
  • Knockdown of ATF2 or ATF7 impairs cell proliferation and M-phase progression, with ATF7 knockdown having a severe effect.
  • A non-phosphorylatable ATF7 mutant inhibits G2/M progression.
  • Mitotic phosphorylation of ATF7 activates Aurora kinases, essential for mitosis.

Conclusions:

  • Cdk1-mediated phosphorylation of ATF7 plays a critical role in facilitating G2/M progression.
  • Mitotic phosphorylation of ATF7 contributes to cell cycle progression by activating Aurora signaling pathways.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

3.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K